Phenomenex Launches Endrix Long Life LC Column to Enhance Durability and Analytical Consistency

Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences,  introd...

June 04, 2026 | Thursday | News
Zymo Research Launches End-to-End NGS Services Portfolio to Accelerate Genomic Discovery

Zymo Research, a global leader in genomics tools, announced the launch of Zymo Services, a dedicated portfolio of end-to-end next-generation sequencing (...

June 04, 2026 | Thursday | News
Skyhawk Reports 12-Month Clinical Improvement and 69% mHTT Reduction with SKY-0515 in Huntington's Disease

Twelve-month findings showed improvement in Composite Unified Huntington's Disease Rating Scale (cUHDRS) scores from baseline of +0.38, compared to an ex...

June 04, 2026 | Thursday | News
First Foundation Labs and Microsoft Join Forces to Accelerate Life Sciences R&D with Enterprise AI

First Foundation Labs (1FL), a life sciences AI company pioneering clinical and translational reasoning spun out of Luma Group, announced a collaboration...

June 04, 2026 | Thursday | News
IDT and Illumina Collaborate to Streamline End-to-End Oncology NGS Research Workflows

Integrated, push-button oncology research workflows give customers a simplified path from library prep through DRAGEN™-powered secondary analysis ...

June 03, 2026 | Wednesday | News
BioNTech And Bristol Myers Squibb Report Encouraging Phase 2 Data For Pumitamig In First Line NSCLC

First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with ch...

June 02, 2026 | Tuesday | News
Johnson & Johnson’s Apalutamide Regimen Cuts Metastasis Risk In High Risk Localised Prostate Cancer

Compared with patients receiving hormone therapy alone, patients were nine times more likely to havelittle to no cancer remaining in the prostate after s...

June 02, 2026 | Tuesday | News
UCB And Biogen Report Positive Phase 3 Results For Dapirolizumab Pegol In Systemic Lupus Erythematosus

UCB  and Biogen Inc.announced that The Lancet, a world-leading medical journal, has published the full results from the Phase 3 PHOENYCS G...

June 02, 2026 | Tuesday | News
Harnessing AI and Real-World Data to Transform Oncology Research

As artificial intelligence becomes increasingly embedded in healthcare research, the ability to generate reliable, transparent, and regulatory-grade eviden...

May 01, 2026 | Friday | Interview
Advancing Equity in Precision Oncology: Insights from Real-World Genomic Testing Trends in Metastatic Prostate Cancer

As precision medicine continues to reshape cancer care, ensuring equitable access to genomic testing remains a critical priority. New research presented at...

June 01, 2026 | Monday | Interaction
Achieving the Promise of Biosimilars: Expanding Access, Affordability, and Healthcare Equity

As healthcare systems around the world grapple with rising costs, growing chronic disease burdens, and increasing demand for innovative therapies, biosimil...

June 01, 2026 | Monday | Interview
Agilent Technologies CEO Padraig McDonnell Highlights Strong Q2 FY26 Performance as Company Raises Full-Year Revenue and EPS Guidance

Delivers strong Q2 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Second-qua...

May 29, 2026 | Friday | Company results
ILC Dover Expands Life Sciences Capabilities with New WFI Manufacturing and Custom Chemical Solutions Services

WFI manufacturing and other capabilities support for pharmaceutical innovation, GLP‑1 therapies, and medical devices. ILC Dover, an Ingersoll Rand bus...

May 28, 2026 | Thursday | News
Ginkgo Bioworks Launches ADME-One™ Integrated ADME Platform for AI-Driven Drug Discovery

Ginkgo Bioworks announced that its Datapoints offering is launching ADME-One™, a fully integrated ADME platform for drug discovery teams co-de...

May 28, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close